Elsevier

Microelectronic Engineering

Volume 158, 1 June 2016, Pages 41-45
Microelectronic Engineering

Agarose multi-wells for tumour spheroid formation and anti-cancer drug test

https://doi.org/10.1016/j.mee.2016.03.009Get rights and content

Highlights

  • A facile technique to fabricate agarose multi-wells is developed.

  • Millimetre size tumour spheroids could be generated in 2 mm diameter agarose wells.

  • The size of tumour spheroids did not increase after a certain limit.

  • The effect of anticancer drug is more efficient at early days.

Abstract

Cell-based assays can be applied to evaluate the efficiency of anti-cancer drugs but the conventional approaches are mostly based on two-dimensional cell culture which is not able to recapitulate the tumour specificity. Here we developed a method to culture millimetre size tumour spheroids that is useful for anticancer drug studies. Agarose multi-wells were obtained by casting on polymethylsiloxane (PDMS) mould, which were then used for culture of U87-MG human glioblastoma. As expected, large size tumour spheroids could be generated after 24 h incubation. Comparing to the multi-well systems made of PDMS or polyethylene glycol diacrylate (PEGDA), agarose multi-wells are clearly advantageous due to the hydrophobic surface and the high permeability of agarose. After culture for 10 days, the tumour spheroids in agarose wells stopped to grow and the further increase of the cell seeding density had no effect on the final size of the spheroids. To study the anticancer drug effect, combretastatin A-4 (CA4) was added on day 2 or day 4, showing clear effects on the tumour spheroids and cell viability. More importantly, the live/dead cell staining images suggested that an earlier drug treatment was more efficient to prohibit the tumour spheroid growth.

Introduction

Cancer metastasis is a leading cause of mortality in the world for which tremendous efforts are now devoted to anti-cancer drug development [1], [2], [3]. Before metastasis, a primary tumour was formed at the anatomical site where tumour progression started to yield a cancerous mass. Therefore, one strategy in drug discovery is against the tumour progression. However, the most previously used cell based assays for cancer drug studies are based on two-dimensional (2D) culture which does not take properly into account the three dimensional (3D) characteristics of tumour formation in vivo [4], [5]. Suspension culture is frequently used for multicellular spheroid formation but it is not easy to control the size consistency of the spheroids and to handle them for systematic studies [6], [7]. Suspension culture using spinning flask or rotating bioreactors can improve the size uniformity of the spheroids but undesired shear stress can be introduced during the spheroid formation. Culture with hanging drops can also improve the size uniformity and overcome the problem of mechanical disturbance. This technique is however time-consuming and not easy to perform drug tests during spheroid progression. More recently 2D and 3D patterned substrates are used to support spheroid formation [8], [9]. In particular, various micro-well arrays are proposed for 3D cell aggregation, depending on microfabrication techniques [10], [11]. This approach allows controlling cell population in each spheroid as well as high-throughput screening. However, the available systems are mostly appropriate for small size spheroid formation, which cannot efficiently recapture the spheroid complexity of solid tumours.

To facilitate the diffusion of nutrients, drugs and other factors into the spheroid area, it is also important to form the 3D assays with the materials of high permeability [12]. In this work, we developed a multi-well assay form by agarose moulding. We first describe our technique and then compare the formation of spheroid culture in agarose, PDMS and PEGDA wells. We then show the relevance of agarose wells for the formation of millimetre size tumour spheroids. Finally, the results of anticancer drug test performed on the same platform on the progressing tumours are reported and the potentials of the proposed assay form for other applications are also briefly discussed.

Section snippets

Fabrication of multi-well array

Fig. 1 shows the schematic process flow of multi-well array fabrication. A flat PDMS film of 2 mm thickness was prepared by casting a mixture of PDMS pre-polymer and cross-linker (GE RTV 615) at a ratio of 10:1 on a silicon wafer. After curing at 80 °C for 1 h, the PDMS layer was peeled-off and an array of holes was created on the PDMS layer using a computer numeric controlled (CNC) milling machine and a biopsy punch of 2 mm diameter. Afterward, the PDMS layer was exposed in trimethylchlorosilane

Material comparisons of multi-wells

Multi-wells made of PDMS, PEGDA and hydrogels could be easily obtained by casting or moulding and used for the formation of either tumour spheroids or embryoid bodies [13], [14], [15]. However, their performances for the spheroid formation should be different due to difference in cell compatibility and material permeability. Fig. 2 shows microphotographs of tumour spheroids formed in multi-wells made of PDMS, PEGDA and agarose. After 2 days, spheroid shaped cell aggregates could be found in all

Conclusion

We have demonstrated a simple but reliable technique for the fabrication of agarose multi-wells and their usefulness in anti-cancer drug tests. In 2 mm diameter agarose wells, 1.4 mm diameter U87-MG tumour spheroids can be formed and cultured for many days. Interestingly, the size of the tumour spheroids does not change with the further increase of seeding cell density. Anti-cancer drug CA4 added at different stages of tumour spheroid formation have different drug effects. More systematic studies

Acknowledgment

This work was supported by the European Commission under contract No. 604263 (Neuroscaffolds) and Agence de Recherche Nationale under contract No. ANR-13-NANO-0011-01 (Pillarcell). Y.T. is grateful to the Chinese Scholar Council for grant.

Cited by (36)

  • Recent advances on cancer-on-chip models: Development of 3D tumors and tumor microenvironment

    2022, Bioprinting
    Citation Excerpt :

    Liquid overlay method: Relying on the prevention of cell adhesion to the culture surface, they are liquid-overlay methods that encourage spheroids and cell aggregates formation [49]. Usually, the adhesion is prevented by various culture surface coating, including agar, agarose, poly (2-hydroxyethyl methacrylate) (polyHEMA) or tri-block co-polymers, such as Pluronic (F108) [50–52]. Other non-adherent surfaces also showed the formation of spheroid due to their topography or hydrophilicity.

  • Emerging tumor-on-chips with electrochemical biosensors

    2022, TrAC - Trends in Analytical Chemistry
  • An alternative approach to tracing the volumic proliferation development of an entire tumor spheroid in 3D through a mini-Opto tomography platform

    2022, Micron
    Citation Excerpt :

    Agarose hydrogel has a permeable structure, which facilitates the diffusion of factors like nutrients, drugs, gas, and small biomolecules. Due to its transparency, cells’ adhesion to the agarose surface and accumulation in the cell mass can be observed easily (Tang et al., 2016). Tumor spheroids, also called tumoroid, could be produced with the 3D cell culture technique by seeding tumor cells into a layer coated with agarose gel.

  • Fabrication of PNIPAm-based thermoresponsive hydrogel microwell arrays for tumor spheroid formation

    2021, Materials Science and Engineering C
    Citation Excerpt :

    Hence, there is a need for methodologies that more closely mimic in vivo environments for cell culture so that the natural environment, 3D architecture, cell morphologies and polarity seen in vivo can be maintained. Technologies that are low cost and practical, and which ensure high reproducibility and better control over spheroid diameters [21] are of great interest. Poly (N-isopropylacrylamide) (PNIPAm) is a thermosensitive and biocompatible polymer frequently used in drug delivery and as biomimetic substrates for cell sheet engineering applications [22–25].

  • Agarose-based biomaterials for advanced drug delivery

    2020, Journal of Controlled Release
    Citation Excerpt :

    They observed cell growth to fill 70% of agarose well diameters, and then it stopped growing, so with the rise of seed cell thickness, the size of tumor spheroids did not alter. The potential of this system to deliver a cargo was studied by adding combretastatin A-4 as an anticancer drug on different days, which showed a direct impact on the cell viability of tumor spheroids [171]. Cell transplantation is also a promising therapeutic strategy to treat different diseases [172,173].

View all citing articles on Scopus
View full text